Nita L. Seibel

机构：National Institutes of Health, National Cancer Institute · ORCID：0000-0001-6259-7955

发表论文 210 篇 · 总被引 14579 次 · h-index 62

代表论文

• Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C (2023 · JNCI Journal of the National Cancer Institute · 被引 100)
• Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group (2023 · Journal of Clinical Oncology · 被引 93)
• Phase II Study of Selumetinib in Children and Young Adults With Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Genetic Alterations: Arm E of the NCI-COG Pediatric MATCH Trial (2022 · Journal of Clinical Oncology · 被引 68)
• Survival outcomes for cancer types with the highest death rates for adolescents and young adults, 1975‐2016 (2021 · Cancer · 被引 57)
• The Childhood Cancer Data Initiative: Using the Power of Data to Learn From and Improve Outcomes for Every Child and Young Adult With Pediatric Cancer (2023 · Journal of Clinical Oncology · 被引 51)
• Precision Medicine in Pediatric Oncology (2019 · Surgical Oncology Clinics of North America · 被引 46)